New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement
Clinical trial NCT02329080 · COMPLETED
Trial details
- NCT number
- NCT02329080
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2019-08-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.